Vanderbilt University Medical Center nephrologist and Associate Professor of Medicine Dr. William H. Fissell IV, is making major progress on a first-of-its kind device to free kidney patients from dialysis. He is building an implantable artificial kidney with microchip filters and living kidney cells that will be powered by a patient’s own heart.
“We are creating a bio-hybrid device that can mimic a kidney to remove enough waste products, salt and water to keep a patient off dialysis,” said Fissell.
Fissell says the goal is to make it small enough, roughly the size of a soda can, to be implanted inside a patient’s body.
The key to the device is a microchip.
“It’s called silicon nanotechnology. It uses the same processes that were developed by the microelectronics industry for computers,” said Fissell.
The chips are affordable, precise and make ideal filters. Fissell and his team are designing each pore in the filter one by one based on what they want that pore to do. Each device will hold roughly fifteen microchips layered on top of each other.
But the microchips have another essential role beyond filtering.
“They’re also the scaffold in which living kidney cells will rest,” said Fissell.
Fissell and his team use live kidney cells that will grow on and around the microchip filters. The goal is for these cells to mimic the natural actions of the kidney.
“We can leverage Mother Nature’s 60 million years of research and development and use kidney cells that fortunately for us grow well in the lab dish, and grow them into a bioreactor of living cells that will be the only ‘Santa Claus’ membrane in the world: the only membrane that will know which chemicals have been naughty and which have been nice. Then they can reabsorb the nutrients your body needs and discard the wastes your body desperately wants to get rid of,” said Fissell.
Because this bio-hybrid device sits out of reach from the body’s immune response, it is protected from rejection.
“The issue is not one of immune compliance, of matching, like it is with an organ transplant,” said Fissell.
The device operates naturally with a patient’s blood flow.
“Our challenge is to take blood in a blood vessel and push it through the device. We must transform that unsteady pulsating blood flow in the arteries and move it through an artificial device without clotting or damage.”
And that’s where Vanderbilt biomedical engineer Amanda Buck comes in. Buck is using fluid dynamics to see if there are certain regions in the device that might cause clotting.
“It’s fun to go in and work in a field that I love, fluid mechanics, and get to see it help somebody,” said Buck.
Vanderbilt biomedical engineer Amanda Buck is using fluid dynamics to see if there are certain regions in the device that might cause clotting.
Fissell says he has a long list of dialysis patients eager to join a future human trial. Pilot studies of the silicon filters could start in patients by the end of 2017.
The Latest on: Artificial Kidney
via Google News
The Latest on: Artificial Kidney
- Wearable Artificial Organs, Inc. Granted Patent for the Wearable Artificial Kidney (WAK) 3.0on March 3, 2021 at 4:05 pm
Patent approved for wearable dialysis device, marking a significant advance in renal (kidney) disease treatment.
- Carrick Capital Partners Announces Growth Recapitalization of Renalogicon March 3, 2021 at 2:25 pm
Press Release Carrick Capital Partners (Carrick), a growth-oriented investment firm focused on software and software-enabled businesses with more than $1B in assets under management has made a ...
- Electronic Nose Uses Solid-state Sensors and Neural Processor to “Sniff Out” COVID-19on March 3, 2021 at 9:45 am
COVID-19 is the latest disease to join that diagnostic list. Like many other "electronic noses," the DiaNose works by detecting volatile organic compounds (VOCs) present in the breath. VOC levels can ...
- Carrick invests in Renalogicon March 3, 2021 at 2:55 am
Carrick Capital Partners (Carrick), a growth-oriented investment firm focused on software and software-enabled businesses with more than $1B in assets under management has made a significant ...
- Kidney Function Tests Market Size Worth $1.25 Billion By 2028 | CAGR 6.2%: Grand View Research, Inc.on March 3, 2021 at 1:22 am
The global kidney function tests market size is expected to reach USD 1.25 billion by 2028 registering a CAGR of 6.2% from 2021 to 2028, according to a new report by Grand View Research, Inc. The ...
- RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021on March 2, 2021 at 4:08 am
Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (“RenalytixAI” or the “Company”), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney ...
- Renalytix AI and University of Utah announce partnership to improve kidney healthon February 26, 2021 at 10:55 am
Renalytix AI plc, an artificial intelligence-enabled in vitro diagnostics company, and the University of Utah, one of the top research institutions in the United States, today announced a partnership ...
- Animal Artificial Insemination Market 2021: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast Till 2029 | FMI Reporton February 26, 2021 at 7:41 am
A recent market study published by Future Market Insights (FMI) on the animal artificial insemination market offers global industry analysis for 2014-2018 & opportunity assessment for 2019-2029. The ...
- National Kidney Month Brings New Push For Organ Donor Job Protectionson February 25, 2021 at 8:05 am
The American Association of Kidney Patients (AAKP), the nation's largest independent and patient-led kidney organization, has mobilized a broad grassroots collaborative of kidney patients, organ ...
- BrainChip Inc. and NaNose Medical Successfully Detect COVID-19 in Exhaled Breath with Fast High-Accuracy Resultson February 24, 2021 at 3:28 pm
BrainChip Inc. and NaNose Medical Successfully Detect COVID-19 in Exhaled Breath with Fast High-Accuracy Results ...
via Bing News